Patents Assigned to GalaGen Inc.
  • Patent number: 5773000
    Abstract: The effective treatment of Clostridium difficile associated diseases, such as Clostridium difficile colitis, pseudomembranous colitis and antibiotic associated diarrhea, by administering an antibody having specific activity against Clostridium difficile colitis and toxins thereof alone or in combination with vancomycin, bacitracin or metronidazole is herein described as well as pharmaceutical compositions therefor.
    Type: Grant
    Filed: October 15, 1996
    Date of Patent: June 30, 1998
    Assignee: GalaGen Inc.
    Inventors: Eileen F. Bostwick, Robert A. Hoerr
  • Patent number: 5707678
    Abstract: Ultrafiltration of whey containing products at an acid pH reduces calcium levels in the concentrate and provides a concentrate that can be consistently microfiltered. The concentrate can be used, for example, in a method of microfiltering milk, milk serum, colostrum, or colostral serum which provides effective bioburden reduction without substantial loss of immunoglobulins.
    Type: Grant
    Filed: April 11, 1996
    Date of Patent: January 13, 1998
    Assignee: GalaGen Inc.
    Inventor: Antone G. Gregory
  • Patent number: 5670196
    Abstract: A method of microfiltering milk, milk serum, colostrum, or colostral serum which provides effective bioburden reduction without substantial loss of immunoglobulins.
    Type: Grant
    Filed: July 26, 1996
    Date of Patent: September 23, 1997
    Assignee: GalaGen Inc.
    Inventor: Antone G. Gregory